Abstract
SMOKING CESSATION IS AN increasingly important area of focus for
pharmaceutical companies, healthcare entities and governments. There are 1.4
billion smokers in the world, and smoking is a known cause of heart disease,
lung cancer, respiratory infections and many other diseases. This has created
a large market for smoking cessation aids.
The market, which Zyban currently holds a tenuous lock on, is about to change,
with a major new brand ready to shake up the current market share. At the same
time, the high incidence of smoking and strong public-sector motivation to
reduce smoking signals room for new entrants.
The market for treatments for alcohol and drug abuse, now dominated by Subutex
and Campral, will also see growth and a robust line of new products.
Kalorama' s Smoking Cessation and Addiction Treatments: A World Market Analysis
covers the market for pharmaceuticals that assist with smoking cessation and
addiction treatment.
Using information gathered for Kalorama' s larger report on Psychotherapeutics:
the World Market and interviews with psychotherapeutic industry insiders
therein, this report takes a more detailed look at the combined market for
both smoking cessation and alcohol/drug addiction treatments. The report
includes:
- Round-up of current products available.
- Market share of major players and brands.
- Forecasted revenues to 2010.
- Forecasted Market Share with consideration of new players.
- Current revenues for 2005.
- World incidence data for Nicotine Addiction, Drug Addiction and Alcohol
Abuse.
- Reviews of new products in the pipeline.
- Key trends driving pharmaceutical treatments for smoking cessation and
drug addiction.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Market Analysis
- Competitive Analysis
- Scope and Methodology
CHAPTER TWO: OVERVIEW
- Nicotine Addiction
- Drug Dependence
- Issues, Trends and� Developments
- Cost Effectiveness of Smoking Cessation
- Therapeutic Benefits
- Importance of Physician Intervention
- Alternative Therapies
- Cautious Optimism for Lower U.S. Smoking
- Genetic Risk Factors for Smoking and Drug Addiction
- Incentive Based Treatments for Drug Abuse
- Reimbursement
- Description of Current Products
- Smoking Cessation
- Chantix/Champix
- Zyban
- Accomplia
- Nicotrol
- Alcohol and Opiate Dependence and Related
- Subutex
- Campral
- Methodone
- ReVia/Naltrex
- Antabuse
- Narcan
- Vivitrol
- Depade
- Research and Development
- Acomplia
- Lofexidine
- Naltrexone Depot
- Lybrel
- SSR591813
- Cyt002-NicQb
- NicVAX
CHAPTER THREE: MARKET DATA AND ANALYSIS
- Markets by Geographical Segments
- U.S. Market
- European Union Market
- Japan and ROW Market
- Market Data by Indication
- Competitive Analysis
CHAPTER FOUR: Company Profiles
- Barr Laboratories, Inc
- Bristol-Myers Squibb
- Cephalon, Inc
- Forest Laboratories, Inc
- GlaxoSmithKline PLC
- Pfizer, Inc
- Sanofi-Aventis
TABLE of EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Exhibit 1: Cost of Smoking, Drug Abuse and Alchohol Addiction Worldwide
- Exhibit 2: Smoking Cessation & Addiction Treatment Market
- Exhibit 3: World Market Smoking Cessation and Addiction Treatments Leading
Suppliers Market Share, Estimated 2005
CHAPTER TWO: OVERVIEW
- Exhibit 4: Estimated World Prevalence of Conditions
- Exhibit 5: Economic Cost of Smoking-Related Illness
- Exhibit 6: Cost of Drug Addiction International and US
- Exhibit 7: Benefits of Smoking Cessation
- Exhibit 8: Recent Smoking Cessation and Addiction Treatment Approvals
- Exhibit 9: Research and Development: Smoking Cessation and Addiction
Treatments
CHAPTER THREE: MARKET DATA AND ANALYSIS
- Exhibit 10: Smoking Cessation & Addiction Treatment: Worldwide Market
- Exhibit 11: World Smoking Cessation & Addiction Treatment Market
- Exhibit 12: World Market: Smoking Cessation and Addiction Treatment Market
by Geographical Segment 2003-2010
- Exhibit 13: World Market Smoking Cessation and Addiction Treatment Market
by Geographical Segment, 2003-2010�
- Exhibit 14: World Market: Smoking Cessation and Addiction Treatment Market
by Geographical Segment - Percent Distribution, 2003-2010
- Exhibit 15: World Market: Smoking Cessation and Addiction Treatment Market
by Geographical Segment and Percent Market Share, 2005
- Exhibit 16: World Market Smoking Cessation and Addiction Treatment Market
by Geographical Segment and Percent Market Share, 2010
- Exhibit 17: Estimated Smoking Cessation and Addiction Treatment Sales by
Indication, 2005
- Exhibit 18: Drug Sales by Indication, 2005
- Exhibit 19: World Market Smoking Cessation and Addiction Treatments
Leading Suppliers Shares by Market Revenues Estimated 2005 and Projected 2010
- Exhibit 20: World Market Smoking Cessation and Addiction Treatments
Leading Suppliers Market Share, Estimated 2005
- Exhibit 21: World Market Smoking Cessation and Addiction Treatments
Leading Suppliers Market Share, Projected 2010
- Exhibit 22: World Market Smoking Cessation and Addiction Treatments
Leading Suppliers Shares by Market Revenues Estimated 2005 and Projected 2010
- Exhibit 23: Smoking Cessation and Addiction Treatment Market Top Drugs by
Estimated Sales and Percent of Market, 2005
- Exhibit 24: Smoking Cessation and Addiction Treatment Market Top Drugs by
Estimated Sales and Percent of Market, 2010
|
